Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer-Reference-Cited by-同舟云学术

Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer

Published:2020-08-04 Issue:4 Volume:126 Page:433-435
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Anton Angelyn¹^ORCID,Kamel Hasan Olfat²³,Ballok Zita⁴,Bowden Patrick⁵,Costello Anthony J.⁶⁷,Harewood Laurence⁶⁸⁹,Corcoran Niall M.⁶⁷⁹,Dundee Phil⁶⁷,Peters Justin S.⁶,Lawrentschuk Nathan²⁸^ORCID,Troy Andrew⁸,Webb David⁸,Chan Yee⁸,See Andrew⁵,Siva Shankar²⁵,Murphy Declan²¹⁰^ORCID,Hofman Michael S.²¹⁰^ORCID,Tran Ben¹²⁸

Affiliation:

1. Walter and Eliza Hall Institute Melbourne Vic.Australia

2. Peter MacCallum Cancer Centre Melbourne Vic. Australia

3. Hamilton Health SciencesMcMaster University Hamilton ON Canada

4. Healthcare Imaging Services Melbourne Vic.Australia

5. ICON Cancer Care Melbourne Vic.Australia

6. Royal Melbourne Hospital Melbourne Vic.Australia

7. Australian Prostate Centre Melbourne Vic.Australia

8. Epworth Healthcare Melbourne Vic.Australia

9. Department of Surgery University of Melbourne Melbourne Vic.Australia

10. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne Vic. Australia

Publisher